Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05102175 · ClinicalTrials.gov registry record

Addressing Health Disparities in African Americans - Exploring Sleep and Developing Interventions

A clinical trial of Sleep, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
36
Enrollment target
1
Study location

NCT05102175: Completed study of Sleep, sponsored by Pennington Biomedical Research Center.

NCT05102175 is a study of Sleep that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 36 participants, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05102175, a study of Sleep, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
36 participants
Enrollment target
1
Study location

Study Summary

The purpose of the HD-SLEEP1 study is to help researchers understand what African Americans know and think about sleep. The investigators also want to know how to encourage people to participate in research studies designed to improve sleep.

Primary Outcome

Identify if sleep is considered important for health

Conditions Studied

Interventions

  • OTHER Focus Group

Study Locations (1)

Louisiana

  • Recruiting core Pennington - Baton Rouge

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2021-11-01
Est. Completion 2022-08-24

What the finished NCT05102175 record still lists

NCT05102175 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Sleep appearing as the primary indexed condition, and to 1 intervention - of which Focus Group is the first listed.

NCT05102175 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT05102175 about?

NCT05102175 is a clinical study titled "Addressing Health Disparities in African Americans - Exploring Sleep and Developing Interventions". The purpose of the HD-SLEEP1 study is to help researchers understand what African Americans know and think about sleep. The investigators also want to know how to encourage people to participate in research studies designed to improve sleep.

What is the current status of trial NCT05102175?

This trial is currently completed. The enrollment target is 36 participants. The study started on 2021-11-01. Estimated completion is 2022-08-24.

What conditions does trial NCT05102175 study?

This clinical trial studies the following conditions: Sleep.

What interventions are being tested in trial NCT05102175?

The interventions under investigation include: Focus Group (OTHER).

Who is sponsoring clinical trial NCT05102175?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05102175 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05102175's enrollment target sits among peer trials

36 111th of 151 higher than 40 of 151 other Sleep trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05102175, the US trial registry maintained by the National Library of Medicine. NCT05102175 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.